3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Prostatic Neoplasms
3
Melanoma
3
Desmoid Tumors
3
Triple Negative Breast Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Disease
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Unresectable Solid Tumors
1
Thyroid Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Respiratory Aspiration
1
Pancreatic Adenocarcinoma Locally Advanced
1
Neuroma
1
Neuralgia
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypesthesia
1
High-Burden Metastatic Solid Tumors
1
Colorectal Neoplasms
1
Interventions
lutetium Lu 177 dotatate
21
Magnetic Resonance Spectroscopy
10
pembrolizumab
9
Specimen Handling
7
Everolimus
7
cabozantinib
6
Nivolumab
6
lenvatinib
5
Capecitabine
5
177Lu-octreotide, DOTA(0)-Tyr(3)-
5
surufatinib
4
olaparib
4
amino-acid, glucose, and electrolyte solution
4
lanreotide
3
atezolizumab
3
Temozolomide
3
Octreotide
3
Lutetium-177
3
Ipilimumab
3
Injections
3
Fluorodeoxyglucose F18
3
Cyclophosphamide
3
gallium Ga 68 dotatate
2
fludarabine phosphate
2
fludarabine
2
avelumab
2
X-Rays
2
Radiotherapy
2
Phantoms, Imaging
2
PM 01183
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
Cryosurgery
×
1 year
×
Clear all
No trials found.